Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00343629 | Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers | completed | N/A | 28 | Mayo ClinicOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT01122888 | Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme | terminated | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT01463982 |
| Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies |
| completed |
| Phase 1 |
| 21 |
| Hanmi Pharmaceutical Company LimitedINDUSTRY |
| 1 |
| Apr 23, 2015 |
| clinicaltrials |
| NCT00278018 | Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors | terminated | Phase 1 / Phase 2 | 20 | Hadassah Medical OrganizationOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00217373 | Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2015 | clinicaltrials |
| NCT00871663 | Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) | completed | Phase 1 | 123 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 20, 2015 | clinicaltrials |
| NCT00682279 | A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Apr 17, 2015 | clinicaltrials |
| NCT00021216 | Bortezomib in Treating Children With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00255658 | Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01603979 | A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors | completed | Phase 1 | 24 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 8, 2015 | clinicaltrials |
| NCT00049400 | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | completed | Phase 1 | 78 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 3, 2015 | clinicaltrials |
| NCT01081808 | Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | terminated | Phase 1 | 2 | Roger Williams Medical CenterOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT01847118 | A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 31 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 24, 2015 | clinicaltrials |
| NCT00769249 | Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Mar 19, 2015 | clinicaltrials |
| NCT00951184 | Depression Screening in Patients Undergoing Radiation Therapy For Cancer | completed | — | 463 | Radiation Therapy Oncology GroupNETWORK | 1 | Mar 18, 2015 | clinicaltrials |
| NCT02390986 | An Extension Study of LON002 in Patients With Cancer | unknown | N/A | 50 | LondonPharma Ltd.INDUSTRY | 1 | Mar 18, 2015 | clinicaltrials |
| NCT01688960 | Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies | completed | Phase 1 | 48 | Regeneron PharmaceuticalsINDUSTRY | 2 | Mar 17, 2015 | clinicaltrials |
| NCT00888043 | Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors(CNTO95/Avastin) | completed | Phase 1 | 13 | Herbert Hurwitz, MDOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01234012 | Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 | completed | Phase 1 | 23 | ImmunoFrontier, Inc.INDUSTRY | 1 | Mar 10, 2015 | clinicaltrials |
| NCT00352443 | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | 66 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00788580 | S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Mar 6, 2015 | clinicaltrials |
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 6 | Cancer Research UKOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01137552 | A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors | terminated | Phase 1 | 44 | AmgenINDUSTRY | 1 | Mar 4, 2015 | clinicaltrials |
| NCT02101164 | Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease | withdrawn | Phase 4 | 0 | AmgenINDUSTRY | 0 | Feb 18, 2015 | clinicaltrials |
| NCT00704054 | A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED) | completed | Phase 1 | 15 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT00781846 | Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED) | completed | Phase 1 | 17 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT01853345 | iCAT for Recurrent/Refractory/HR Solid Tumors | completed | — | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT02049281 | A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) | terminated | Phase 1 | 3 | EndocyteINDUSTRY | 0 | Feb 10, 2015 | clinicaltrials |
| NCT01417403 | Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases | terminated | Phase 1 | 10 | Virginia Commonwealth UniversityOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT01844869 | An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate | completed | Phase 1 | 6 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 1 | Jan 30, 2015 | clinicaltrials |
| NCT00818831 | A Study of QBI-139 in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 30 | Quintessence Biosciences, Inc.INDUSTRY | 1 | Jan 28, 2015 | clinicaltrials |
| NCT00879684 | Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | PfizerINDUSTRY | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02339753 | Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation | unknown | Phase 2 | 24 | The Korean Society of Pediatric Hematology OncologyNETWORK | 1 | Jan 16, 2015 | clinicaltrials |
| NCT01940601 | Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors | withdrawn | Phase 2 | 0 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 0 | Jan 14, 2015 | clinicaltrials |
| NCT00635596 | Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer(MT110-101) | completed | Phase 1 | 65 | Amgen Research (Munich) GmbHINDUSTRY | 1 | Jan 13, 2015 | clinicaltrials |
| NCT00487331 | Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study | completed | N/A | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00665990 | Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia | completed | Phase 1 | 49 | St. Jude Children's Research HospitalOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT02048943 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00968643 | Spinal Cord Compression. ICORG 05-03, V6 | completed | Phase 3 | 126 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01218620 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT00813384 | A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors | completed | Phase 1 | 54 | AmgenINDUSTRY | 1 | Dec 16, 2014 | clinicaltrials |
| NCT00624962 | Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors | withdrawn | N/A | 0 | Vanderbilt UniversityOTHER | 0 | Dec 11, 2014 | clinicaltrials |
| NCT00217477 | Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 34 | Roswell Park Cancer InstituteOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT00964275 | Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein(MVTEP) | completed | N/A | 400 | University Hospital, BrestOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT00984425 | The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors | completed | Phase 1 | 30 | Istituto Clinico HumanitasOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00305799 | Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors | completed | — | 59 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT00276575 | Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 65 | Herbert Hurwitz, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT00586443 | BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)(BEP) | completed | Phase 1 | 56 | Herbert Hurwitz, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Apr 28, 2015source: clinicaltrials